| 1 |
18074444 | In-vitro experimental models for the risk assessment of antibiotic-induced QT prolongation. | 2007 Dec 22 |
2 |
| 2 |
16446155 | Erythromycin block of the HERG K+ channel: accessibility to F656 and Y652. | 2006 Mar 10 |
3 |
| 3 |
17054943 | In-vitro experimental models for the risk assessment of antibiotic-induced QT prolongation. | 2006 Dec 28 |
2 |
| 4 |
17313833 | [Erythromycin inhibits the proliferation of HERG K+ channel highly expressing cancer cells and shows synergy with anticancer drugs]. | 2006 Dec 19 |
3 |
| 5 |
15812674 | HERG K+ channel expression-related chemosensitivity in cancer cells and its modulation by erythromycin. | 2005 Aug |
4 |
| 6 |
16051125 | Exaggerated block of hERG (KCNH2) and prolongation of action potential duration by erythromycin at temperatures between 37 degrees C and 42 degrees C. | 2005 Aug |
3 |
| 7 |
16086867 | [Correlation of HERG K+ channel protein expression to chemosensitivity of tumor cells to doxorubicin and its modulation by erythromycin]. | 2005 Aug |
1 |
| 8 |
14674677 | Characterization of the inhibitory effects of erythromycin and clarithromycin on the HERG potassium channel. | 2003 Dec |
3 |
| 9 |
9694927 | Blockade of HERG and Kv1.5 by ketoconazole. | 1998 Aug |
1 |